VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
NPM-ALK oncogenic kinase promotes cell-cycle progression through activation of JNK/cJun signaling in anaplastic large-cell lymphoma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
NPM-ALK oncogenic kinase promotes cell-cycle progression through activation of JNK/cJun signaling in anaplastic large-cell lymphoma.
NPM-ALK oncogenic kinase promotes cell-cycle progression through activation of JNK/cJun signaling in anaplastic large-cell lymphoma. Blood. 2007 Sep 01; 110(5):1621-30.
View in:
PubMed
subject areas
Anthracenes
Cell Cycle
Cell Transformation, Neoplastic
Chromosomes, Human, Pair 2
Chromosomes, Human, Pair 5
Cyclin A
Cyclin D3
Cyclins
Dose-Response Relationship, Drug
Down-Regulation
Enzyme Activation
Humans
Jurkat Cells
Lymphoma, Large B-Cell, Diffuse
Mitogen-Activated Protein Kinase 8
Mitogen-Activated Protein Kinase 9
Oncogene Proteins, Fusion
p21-Activated Kinases
Phosphorylation
Protein-Tyrosine Kinases
Signal Transduction
Transcription Factor AP-1
Transcription, Genetic
Translocation, Genetic
Up-Regulation
authors with profiles
FRANCOIS-XAVIER CLARET
L JEFFREY MEDEIROS